UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325

Comparison of subjective and objective evaluations of the status of patients with primary depressive disorders with the aim to substantiating of therapeutic tactics

Type of Article

In the Section

Index UDK:

Abstract

The article presents the results of clinical and psychopathological research, which indicate a definite difference between the objective assessment of the "severity" of the depressive episode and the subjective evaluation by patients of their condition and can be used as targets of psychotherapeutic eff ect. The eff ectiveness of using cognitive-behavioral therapy as the leading method of psychotherapy for this category of patients is substantiated, which allows changing the patient’s perception of oneself and his/her abilities to more positive ones, to improve social adaptation of patients, to improve relationships with others, to reduce self-accusations.

Pages

References

  1. Maruta N. A., Venger E. P. Clinical and psychopathological features of depressive disorders in emigrants and re-emigrants // Norwegian Journal of Development of International Science. 2017. No. 12. P. 59–64.
  2. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STARD report / A. J. Rush, M. H. Trivedi, S. R. Wisniewski [et al.] // Am. J. Psychiatry. 2006. Vol. 163. P. 1905—1917.
  3. Richardson K., Barkham M. Recovery from depression: a systematic review of perceptions and associated factors // J Ment Health. 2017. Sep 6. P. 1—13.
  4. Maruta, N. O., Zhupanova, D. O. Kliniko-psykholohichni osoblyvosti khvorykh na depresiiu z riznym rivnem medykamentoznoho komplaiensu (diahnostyka i korektsiia). Ukrainskyi visnyk psykhonevrolohii. 2016. T. 24, vyp. 1 (86). C. 5–11.
  5. Pugovkina O. D. Mindfulness-based cognitive therapy: cognitive psychotherapy based on mindfulness in the treatment of chronic depression // Modern therapy of mental disorders. 2014. Vol. 2. P. 26—32.
  6. Risk factors for treatment resistance in unipolar depression: A systematic review / D. Bennabi, B. Aouizerate, W. El-Hage [et al.] // J. Affect. Disord. 2015. Vol. 171. P. 137—141.
  7. Identifying Depressive Subtypes in a Large Cohort Study: Results from the Netherlands Study of Depression and Anxiety (NESDA) / Lamers F., de Jonge P., Nolen W. A. [et al.] // J Clin Psychiatry. 2010. Vol. 71 (12). P. 1582—1589.
  8. Maruta N. A., Yavdak I. A., Cherednyakova E. S. Evaluation of neurotrophic therapy for depression // International Neurological Journal. 2017. No. 3 (89). Pp. 29–38.
  9. Conradi H. J., Ormel J., de Jonge P. Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study // Psychol Med. 2011. Vol. 41. P. 1165—1174.
  10. Richelson E. Multi-modality: a new approach for the treatment of major depressive disorder // Int. J. Neuropsychopharmacol. 2013. Vol. 16, No. 6. P. 1433—1442.
  11. Smulevich A. B. Depression in somatic and psychiatric diseases / A. B. Smulevich. Moscow: Medical Information Agency, 2003: 209 p.
  12. Busner, J., Targum S. D. The clinical global impressions scale: applying a research tool in clinical practice // Psychiatry (Edgmont). 2007. Vol. 4 (7). P. 28—37.